These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1099982)

  • 1. Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens.
    Maderazo EG; Quintiliani R; Tilton RC; Bartlett R; Joyce NC; Andriole VT
    Antimicrob Agents Chemother; 1975 Jul; 8(1):54-7. PubMed ID: 1099982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline.
    Montgomerie JZ; Pickett MJ; Yoshimori RN; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1976 Jul; 10(1):102-5. PubMed ID: 791084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus.
    Crues JV; Murray BE; Moellering RC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):690-2. PubMed ID: 526013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima).
    Kuck NA
    Antimicrob Agents Chemother; 1976 Mar; 9(3):493-7. PubMed ID: 176936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Acinetobacter calcoaceticus (Herellea vagincola) to tetracycline and minocycline.
    Thomas ET; Coleman C; Talantis K; Armstrong M
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):140-4. PubMed ID: 812659
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
    Castanheira M; Mendes RE; Jones RN
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of a new thiatetracycline antibiotic, thiacycline, in comparison with tetracycline, doxycycline and minocycline.
    Russell AD; Ahonkhai I
    J Antimicrob Chemother; 1982 Jun; 9(6):445-9. PubMed ID: 7050073
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycoside-modifying enzymes among clinical isolates of Acinetobacter calcoaceticus subsp. anitratus (Herellea vaginicola): explanation for high-level aminoglycoside resistance.
    Murray BE; Moellering RC
    Antimicrob Agents Chemother; 1979 Feb; 15(2):190-9. PubMed ID: 426512
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.
    Glew RH; Moellering RC; Kunz LJ
    Medicine (Baltimore); 1977 Mar; 56(2):79-97. PubMed ID: 846390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].
    Dabernat H; Delmas C; Bauriaud R; Lareng MB
    Pathol Biol (Paris); 1983 May; 31(5):413-8. PubMed ID: 6353333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus.
    Obana Y; Nishino T; Tanino T
    J Antimicrob Chemother; 1985 Apr; 15(4):441-8. PubMed ID: 4008377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing.
    Washington JA; Yu PK; Martin WJ
    Appl Microbiol; 1970 Feb; 19(2):259-63. PubMed ID: 4392357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use.
    Lewis SA; Altemeier WA
    Chemotherapy; 1976; 22(5):319-23. PubMed ID: 947710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S57-74. PubMed ID: 184213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Huband MD; Mendes RE; Pfaller MA; Lindley JM; Strand GJ; Benn VJ; Zhang J; Li L; Zhang M; Tan X; Liu Q; Flamm RK
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline.
    Chow AW; Patten V; Guze LB
    Antimicrob Agents Chemother; 1975 Jan; 7(1):46-9. PubMed ID: 1137358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.